Ligand · FJ5
FJ5 · N-{3-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazol-5-yl}cyclopropanecarboxamide
FJ5, N-{3-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazol-5-yl}cyclopropanecarboxamide (C27 H31 N3 O5, 477.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- FJ5
- Formula
- C27 H31 N3 O5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
FJ5 in 2 structures; the first of them:
- 4LWH · Crystal Structure of the human Hsp90-alpha N-domain bound to the hsp90 inhibitor FJ5 · FJ5 A301 · binds LEU48, ASN51, SER52, ASP54, ALA55, LYS58, ASP93, ILE96 and 10 more
- 4LWH · Crystal structure of the human HSP90-alpha N-domain bound to the HSP90 inhibitor FJ5 · FJ5 A301 · binds LEU48, ASN51, SER52, ASP54, ALA55, LYS58, ASP93, ILE96 and 10 more
Residues it binds most
GLY 2, ASP 2, LEU 2, THR 2, VAL 2, ALA 2, ASN 2, ILE 2, LYS 2, MET 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.